EUVIMEDEUVIMED entdecken
Crossref

Radiolabeled Albumin Bound Fibroblast Activation Protein (FAP) Inhibitor-04 Enhances Precision in Renal Fibrosis Diagnosis via PET Imaging

Qi Yang, Tingfei Gu, Zhao Chen, Mengxin Xu, Yongkang Qiu, Wenpeng Huang, Tianyao Wang iD, Lele Song, Zhibo Liu iD, Lei Kang iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c20457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Qi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Kidney, Albumins, Acute Kidney Injury. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis is a critical pathological feature of both acute kidney injury (AKI) and chronic kidney disease (CKD), yet noninvasive methods for early detection remain limited. Current imaging tracers, such as 18F-FDG and 68Ga-FAPI-04, suffer from poor specificity and renal clearance, hindering accurate fibrosis assessment. This study aimed to evaluate the 68Ga-TE-FAPI-04 tracer as a promising tool for precise characterization of renal fibrosis across disease stages. 68Ga-TE-FAPI-04 was synthesized by conjugating a FAP inhibitor with an albumin-binding moiety. Its performance was systematically evaluated in murine unilateral (early stage) and bilateral (advanced-stage) ischemia-reperfusion injury (IRI) models using longitudinal PET/CT imaging, biodistribution studies, histopathological correlations, and functional examinations. Comparative assessments with 68Ga-FAPI-04 and 18F-FDG were performed. 68Ga-TE-FAPI-04 demonstrated superior sensitivity for detecting active fibrogenesis in unilateral IRI models, with significantly higher uptake in injured kidneys than control kidneys during the critical window of days 7-14 postinjury (day 7, 0.79 ± 0.12 vs 0.51 ± 0.09, P < 0.001; day 10, 0.93 ± 0.17 vs 0.70 ± 0.14, P = 0.001). In bilateral IRI models, it effectively characterized advanced fibrosis, showing strong correlations with functional impairment (serum creatinine: R = 0.857, P = 0.007). The tracer's albumin-binding design enabled prolonged circulation and enhanced target accumulation, overcoming the rapid washout limitations of current FAPI tracers. Histopathological validation confirmed robust correlations between tracer uptake and both interstitial fibrosis (R = 0.847, P < 0.001) and FAP expression (R = 0.755, P < 0.001). 68Ga-TE-FAPI-04 PET/CT represents a paradigm shift in renal fibrosis management, enabling early detection of active fibrogenesis before functional decline, and comprehensive assessment of advanced disease. Its dual capacity to quantify structural changes and reflect functional severity positions it as a precision medicine tool for revolutionizing nephrology practice. Further validation in clinical cohorts will be essential to confirm these preclinical findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyKidneyAlbuminsAcute Kidney InjuryMembrane ProteinsAnimalsMiceFibrosisMaleGallium RadioisotopesMice, Inbred C57BLReperfusion InjuryTissue DistributionEndopeptidasesQuinolinesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

PET/CTdiagnostic imagingfibroblast activation proteinischemia−reperfusion injury modelrenal fibrosis

Substanzen

Gallium RadioisotopesAlbuminsMembrane ProteinsEndopeptidasesQuinolinesFibroblast Activation Protein Alpha68Ga-FAPI

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Changping Laboratory, Beijing 102206, China.
  • Beijing National Laboratory for Molecular Sciences, Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education…
  • Peking University-Tsinghua University Center for Life Sciences, Beijing 100871, China.

ORCID-Profile: Tianyao Wang, Zhibo Liu, Lei Kang

Förderung

  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • National Natural Science Foundation of China
  • Beijing Nova Program
  • National Science and Technology Major Project
  • National High Level Hospital Clinical Research Funding
  • Future Talent Development Plan in the Medical Engineering Field

Zitieren

APA

Yang, Q., Gu, T., Chen, Z., Xu, M., Qiu, Y., Huang, W., Wang, T., Song, L., Liu, Z., & Kang, L. (2025). Radiolabeled Albumin Bound Fibroblast Activation Protein (FAP) Inhibitor-04 Enhances Precision in Renal Fibrosis Diagnosis via PET Imaging. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c20457

Vancouver

Yang Q, Gu T, Chen Z, Xu M, Qiu Y, Huang W, et al. Radiolabeled Albumin Bound Fibroblast Activation Protein (FAP) Inhibitor-04 Enhances Precision in Renal Fibrosis Diagnosis via PET Imaging. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c20457

BibTeX
@article{Yang2025,
  author = {Yang, Qi and Gu, Tingfei and Chen, Zhao and Xu, Mengxin and Qiu, Yongkang and Huang, Wenpeng and Wang, Tianyao and Song, Lele and Liu, Zhibo and Kang, Lei},
  title = {Radiolabeled Albumin Bound Fibroblast Activation Protein (FAP) Inhibitor-04 Enhances Precision in Renal Fibrosis Diagnosis via PET Imaging},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c20457}
}
Kostenlos starten →